These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38995462)

  • 1. The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone.
    Toda Y; Ogura K; Iwata S; Kobayashi E; Osaki S; Fukushima S; Mawatari M; Kawai A
    Int J Clin Oncol; 2024 Sep; 29(9):1391-1397. PubMed ID: 38995462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Patients with Giant Cell Tumor of Bone and High Serum Tartrate-Resistant Acid Phosphatase 5b Levels: Comparison of Tumor Volume and Clinical Factors.
    Hayashida K; Kawabata Y; Yoshida T; Saito K; Fujita S; Choe H; Kato I; Takeyama M; Inaba Y
    J Nippon Med Sch; 2022; 89(6):572-579. PubMed ID: 36725001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
    Yao NS; Wu YY; Janckila AJ; Ku CH; Hsieh AT; Ho CL; Lee SH; Chao TY
    Clin Chim Acta; 2011 Jan; 412(1-2):181-5. PubMed ID: 20932965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
    Tsai SH; Chen CY; Ku CH; Janckila AJ; Yam LT; Yu JC; Chuang KW; Chao TY
    Mayo Clin Proc; 2007 Aug; 82(8):917-26. PubMed ID: 17673059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.
    Chao TY; Yu JC; Ku CH; Chen MM; Lee SH; Janckila AJ; Yam LT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):544-50. PubMed ID: 15701839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
    Qin YJ; Zhang ZL; Zhang H; Hu WW; Liu YJ; Hu YQ; Li M; Gu JM; He JW
    Acta Pharmacol Sin; 2008 Dec; 29(12):1493-8. PubMed ID: 19026169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of TRACP5b expression in patients with bone tumors.
    Zhang Q; Cao L; Miao XD; Wu YP
    J Biol Regul Homeost Agents; 2019; 33(2):557-562. PubMed ID: 30973000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP.
    Sarvari BK; Sankara Mahadev D; Rupa S; Mastan SA
    Indian J Clin Biochem; 2015 Jan; 30(1):66-71. PubMed ID: 25646043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.
    Brady JJ; Crowley RK; Murray BF; Kilbane MT; O'Keane M; McKenna MJ
    Ir J Med Sci; 2014 Mar; 183(1):47-52. PubMed ID: 23737138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Diagnosis and Recurrence Detection of Giant Cell Tumor of Bone.
    Shinozaki T; Saito K; Kobayashi T; Yanagawa T; Takagishi K
    Open Orthop J; 2012; 6():392-9. PubMed ID: 22962569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications.
    Chen J; Younusi A; Cao L; Xu L; Zhou Y; Zhen T; Song X
    Clin Lab; 2015; 61(8):1077-81. PubMed ID: 26427154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.
    Abe S; Yoshihisa A; Ichijo Y; Kimishima Y; Yokokawa T; Misaka T; Sato T; Oikawa M; Kobayashi A; Kaneshiro T; Nakazato K; Takeishi Y
    CJC Open; 2021 Apr; 3(4):470-478. PubMed ID: 34027350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
    Feng C; Zhan Y; Shao H; Wang Z; Zhu S
    J BUON; 2020; 25(2):688-695. PubMed ID: 32521854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population.
    Kikuchi W; Ichihara K; Mori K; Shimizu Y
    Ann Clin Biochem; 2021 Jul; 58(4):358-367. PubMed ID: 33715446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
    Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
    J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA.
    Nwosu LN; Allen M; Wyatt L; Huebner JL; Chapman V; Walsh DA; Kraus VB
    Osteoarthritis Cartilage; 2017 Jun; 25(6):858-865. PubMed ID: 28087412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
    Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
    Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.